|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/18 | |
| C07K 14/50 |
| (11) | Number of the document | 2427208 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10718381.6 |
| Date of filing the European patent application | 2010-05-04 | |
| (97) | Date of publication of the European application | 2012-03-14 |
| (45) | Date of publication and mention of the grant of the patent | 2017-04-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/033478 |
| Date | 2010-05-04 |
| (87) | Number | WO 2010/129503 |
| Date | 2010-11-11 |
| (30) | Number | Date | Country code |
| 175736 P | 2009-05-05 | US | |
| 285118 P | 2009-12-09 | US |
| (72) |
BELOUSKI, Edward John, US
ELLISON, Murielle Marie, US
HAMBURGER, Agnes Eva, US
HECHT, Randy Ira, US
LI, Yue-Sheng, US
MICHAELS, Mark Leo, US
SUN, Jeonghoon, US
XU, Jing, US
|
| (73) |
Amgen, Inc,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (54) | FGF21 MUTANTS AND USES THEREOF |
| FGF21 MUTANTS AND USES THEREOF |